EVO Payments Announces Pricing of Offering of 5,000,000

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
66
EVO Payments Announces Pricing of Offering of 5,000,000 Shares of Common Stock

ATLANTA, April 03, 2019 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (NASDAQ: EVOP) (“EVO” or the “Company”) announced today the pricing of an underwritten offering of 5,000,000 shares of Class A common stock at a price to the public of $26.50 per share, pursuant to a registration statement filed on Form S-1 with the Securities and Exchange Commission. The Company has granted the underwriters a 30-day option to purchase up to 750,000 additional shares of Class A common stock. The offering is expected to close on April 8, 2019, subject to customary closing conditions.

The Company intends to use all of the net proceeds received by the Company from the sale of shares of its Class A common stock in the offering (other than shares sold pursuant to the underwriters’ option to purchase additional shares) to purchase (i) LLC interests in EVO Investco, LLC (“EVO LLC”) and paired shares of the Company’s Class D common stock from entities affiliated with Madison Dearborn Partners, LLC and (ii) LLC interests in EVO LLC and paired shares of the Company’s Class B common stock from Blueapple, Inc., in each case at a purchase price per LLC interest and paired share of Class B or D common stock equal to the public offering price per share of Class A common stock less underwriting discounts and commissions. The Company intends to use all of the net proceeds received by the Company from any sale of shares of Class A common stock to the underwriters upon exercise of their option to purchase additional shares to purchase an equivalent number of LLC interests in EVO LLC directly from EVO LLC at a purchase price per LLC interest equal to the public offering price per share of Class A common stock less underwriting discounts and commissions. EVO LLC anticipates that it will use any net proceeds from the sale of LLC interests to the Company to repay borrowings under the Company’s senior secured credit facilities.

J.P. Morgan is acting as the lead book-running manager for the offering and as representative of the underwriters. Barclays, BofA Merrill Lynch, Citigroup, Deutsche Bank Securities, Goldman Sachs & Co. LLC, SunTrust Robinson Humphrey and William Blair are acting as book-running managers for the offering.

The offering will be made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue Edgewood, New York 11717 Attn: Prospectus Group.

A registration statement on Form S-1 relating to these securities (the “Registration Statement”) was filed with, and declared effective by, the Securities and Exchange Commission. The Registration Statement can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About EVO Payments, Inc.

EVO Payments, Inc. (NASDAQ: EVOP) is a leading payment technology and services provider. EVO offers an array of innovative, reliable, and secure payment solutions to merchants ranging from small and mid-size enterprises to multinational companies and organizations across North America and Europe. As a fully integrated merchant acquirer and payment processor in over 50 markets and 150 currencies worldwide, EVO provides competitive solutions that promote business growth, increase customer loyalty, and enhance data security in the international markets it serves.

Forward Looking Statements

This announcement includes forward-looking statements. Forward-looking statements are subject to risks and uncertainty. They are not guarantees of future performance, and the Company’s actual results could differ materially from the expectations expressed or implied in any forward-looking statements. You should not put undue reliance upon them. Words such as “anticipates,” “believes,” “continues,” “estimates,” “expects,” “goal,” “objectives,” “intends,” “may,” “opportunity,” “plans,” “potential,” “near-term,” “long-term,” “projections,” “assumptions,” “projects,” “guidance,” “forecast,” “outlook,” “target,” “should,” “could,” “would,” “will” and comparable words are a common way to identify forward-looking statements. Examples of forward-looking statements contained in this release include statements about the Company’s use of proceeds from the offering. Actual results may differ from those contained in any forward-looking statements made in this release for a variety of reasons, including those described in “Risk factors” and “Forward-looking statements” in the Registration Statement and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission.

Contact:
Sarah Jane Perry
Investor Relations & Corporate Communications Manager 770-709-7365
investor.relations@evopayments.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 70

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
AptarGroup Faces Investigation: Shareholder Stakes High

Updated Category News Views 89

AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...

Continue Reading
24X Partners with Standard Chartered for Crypto Leap

Updated Category News Views 86

24X Steps Up the Game with Crypto Addition You gotta give it to 24X—they're not just twiddling their thumbs in the background. These folks in Bermuda have snagged another feather in their cap by expanding their partnership with heavyweight Standard Chartered, bringing Bitcoin and Ethereum into the mix. We're talking big moves here as 24X becomes the first to offer...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 191

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Sino Biological Boosts AI Protein Discovery Efficiency

Updated Category News Views 37

Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...

Continue Reading
VT Markets Unites Trading and Drama in New Finale

Updated Category News Views 76

Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...

Continue Reading
Poland's Economic Boom: A Case for Freedom and Growth

Updated Category News Views 60

Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 81

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
AION Labs Elevates Leadership, Eyes New R&D Horizons

Updated Category News Views 70

Setting New Standards in Pharma Innovation The air in Rehovot, Israel might be filled with more than just technological aspirations, thanks to AION Labs stepping up its leadership game. This venture studio doesn't seem content to rest on its laurels. Nope, it's diving headlong into the deeper end of pharma R&D, scouting out fresh tech territories like quantum computing...

Continue Reading
1-800Accountant Secures Global Win in Tax Services

Updated Category News Views 53

Another Feather in the Cap for 1-800Accountant You don’t get to be at the top of your game without turning a few heads. And 1-800Accountant has done just that, snagging the Fall 2026 Clutch Global Award for their expertise in the accounting universe. The Importance of Listening In this day and age, businesses large and small are realizing that the voice of the client is...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Fundraising Campaign to Restore Food Bank Services

Updated Category News Views 160

Transforming Community Support Through Art and Action In the wake of devastating wildfires that impacted a significant area, a new initiative is taking shape to assist those affected. This unique campaign combines the power of art and activism to address an urgent community need: the restoration of a food bank that has served countless families over the past two decades....

Continue Reading
OYO Expands Horizons with Acquisition of G6 Hospitality

Updated Category News Views 67

OYO Acquires G6 Hospitality: A Major Strategic Move In a significant development, Oravel Stays, the parent company of OYO, has announced its acquisition of G6 Hospitality from Blackstone Real Estate for $525 million. This all-cash deal aims to strengthen OYO's presence in the U.S. hospitality industry. Growing Presence in the United States Since diving into the U.S....

Continue Reading
Dizal's Sunvozertinib Receives FDA Priority Review for NSCLC

Updated Category News Views 262

FDA's Priority Review of Sunvozertinib: A Game Changer for NSCLC Dizal is making headlines with the announcement that the U.S. Food and Drug Administration (FDA) has granted priority review for the company's New Drug Application (NDA) for Sunvozertinib. This oral EGFR inhibitor holds the promise of offering a significant treatment option for patients suffering from...

Continue Reading
Deep Dive into Masimo Corporation's Ongoing Legal Troubles

Updated Category News Views 294

Masimo Corporation Under Scrutiny Recently, the spotlight has turned to Masimo Corporation (NASDAQ: MASI) as investigations unfold regarding potential misconduct among its leadership. The inquiry is spearheaded by Charles C. Foti, Jr., a former Attorney General of Louisiana and partner at Kahn Swick & Foti, LLC. Revenue Shortfalls and Investor Concerns The company faced a...

Continue Reading
PMV Pharmaceuticals Unveils Promising Monotherapy Data for Solid Tumors

Updated Category News Views 471

Exciting Developments in Cancer Treatment In the realm of precision oncology, PMV Pharmaceuticals continues to lead the charge with groundbreaking research that shines a spotlight on novel therapies. Today, the company has presented updated interim data that promises to reshape the treatment landscape for patients dealing with advanced solid tumors, particularly those...

Continue Reading